New York (February 5th, 2013) - Sonus Networks, Inc. (NASDAQ: SONS) announced that it will report financial results for the fourth quarter and full year 2012 after the close of the market on Thursday, February 28, 2013. Following the release, Sonus Networks will host a conference call with the financial community at to discuss the results.
Sonus Networks, Inc. is a leader in IP networking with proven expertise in delivering secure, reliable and scalable next-generation infrastructure and subscriber solutions. With customers in over 50 countries across the globe and over a decade of experience in transforming networks to IP, Sonus has enabled service providers and enterprises to capture and retain users and generate significant ROI.
Find out how this announcement could benefit SONS by getting the free full report here:
Delcath Systems, Inc. (NASDAQ: DCTH) announced that the Institutfür das EntgeltsystemimKrankenhaus (InEk), the German federal reimbursement agency, has established a reimbursement pathway for the treatment of patients with liver metastases with the Delcath Hepatic CHEMOSAT® Delivery System for melphalan hydrochloride.
Delcath Systems, Inc. is a specialty pharmaceutical and medical device company focused on oncology. Delcath`s proprietary system for chemosaturation is designed to administer high dose chemotherapy and other therapeutic agents to diseased organs or regions of the body, while controlling the systemic exposure of those agents.
Delcath Systems, Inc. (DCTH) announced that the Institutfür das Entgeltsystemim Krankenhaus.
Find out where DCTH could be headed by getting the free full report here: